Home » Clinical Trials »  Search Clinical Trials

Therapeutic Areas:  |  Oncology  |  Family Medicine

Search Medical Condition
Please enter condition
Please choose location
Clear Trial Filters

Chemotherapy Clinical Trials

A listing of Chemotherapy medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.


Found (12) clinical trials

A clinical research study of S-1 de-escalation, Chemotherapy by Investigator's choice for the treatment of Esophageal Adenocarcinoma, Gastric Cancer, Unresectable, Locally Advanced or Metastatic, Adenocarcinoma of the Stomach, or of the Gastro Esophageal Junction, Gastroesophageal Junction Adenocarcinoma, Esophageal Cancer, Gastric Adenocarcinoma

Open-label, multi-center, controlled, randomized, parallel-group phase II trial in patients with metastatic esophagogastric cancer having received induction chemotherapy. Patients will be registered before or after application of a three-months induction chemotherapy . This 12-week induction therapy will consist of one of the following regimens: FLO/mod. Folfox-6, Cisplatin/5-FU, Cisplatin/S-1, FLOT, EOX/EOF ...


A clinical trial to evaluate treatments using Chemotherapy, Capecitabine, Gemcitabine Hydrochloride, Erlotinib Hydrochloride, Fluorouracil for patients with Stage IIA Pancreatic Cancer AJCC v6 and v7, Pancreatic Intraductal Papillary-Mucinous Neoplasm, Pancreatic Ductal Adenocarcinoma, Stage IIB Pancreatic Cancer AJCC v6 and v7, Stage IA Pancreatic Cancer AJCC v6 and v7, Pancreatic Acinar Cell Carcinoma, Stage IB Pancreatic Cancer AJCC v6 and v7

PRIMARY OBJECTIVES: I. To determine whether the addition of erlotinib (erlotinib hydrochloride) to gemcitabine (gemcitabine hydrochloride) adjuvant chemotherapy shows a signal for improved survival as compared to gemcitabine alone following R0 or R1 resection of head of pancreas adenocarcinoma (including adenocarcinoma of the head, neck, and uncinate process). (Phase II-R) ...


Patients are needed to participate in a clinical research study to evaluate Metastatic Breast Cancer Starting a Third Line Chemotherapy

This is a biomedical study of interventional type. The trial will include 270 patients (180 patients in the first cohort and 90 patients in a second cohort) over a period of 3 years + 2 years of follow up. This prospective study will be conduct in patients who will receive ...


A clinical trial to evaluate treatments for patients with Dental caries, Oral Complications of Chemotherapy and Head/Neck Radiation, Oral Neoplasm

This research proposal is unique in that it compares two different methods of applying neutral sodium fluoride to prevent dental caries and improve compliance in this at-risk population. Given that compliance with use of fluoride trays has historically been poor, there is controversy as to which application method is best. ...

Phase N/A

A clinical trial to evaluate treatments using Chemotherapy, Navitoclax, Venetoclax for patients with childhood ALL

This dose-escalating study is to determine the safety, pharmacokinetics, and preliminary efficacy of venetoclax in combination with navitoclax and chemotherapy in adult and pediatric participants with relapsed acute lymphoblastic leukemia.


A clinical trial to evaluate treatments using FOLFOX (chemotherapy) for patients with Colorectal Cancer

OUTLINE: This is a multicenter, phase II/III study. Patients are stratified according to ECOG performance status (0 or 1 vs 2) and randomized to 1 of 2 treatment regimens. Patients will receive full supportive care while on this study. OBJECTIVES Primary Phase II component: To assure that neoadjuvant FOLFOX followed ...


Patients are needed to participate in a clinical research study of Central Nervous System Embryonal Tumors, Medulloblastoma to evaluate Tandem 3 Cycle Intensive Chemotherapy, Single Cycle Intensive Chemotherapy, Induction

Due to the inferior response and event-free survival data of Regimens D and D2 on "Head Start III" for all children with supratentorial embryonal tumors, in comparison with the published data from "Head Start II" with Regimen A2 for metastatic patients, all such patients will receive the "Head Start II" ...


A clinical research study of Chemotherapy, ascorbic acid

Linus Pauling and Dr Ewan Cameron have published two retrospective studies about using high dose vitamin C to treat cancer patients forty years ago. Their studies have shown that high dose vitamin C usage could significantly prolong overall survival of patients with advanced cancer. Recently, preclinical study has shown that ...


A clinical research study for the treatment of Childhood Acute Myeloid Leukemia, Untreated Childhood Acute Lymphoblastic Leukemia, Febrile Neutropenia, Hematopoietic Cell Transplantation Recipient, B-Cell Lymphoma, Childhood Neoplasm, Recurrent Childhood Acute Lymphoblastic Leukemia, Childhood Burkitt Lymphoma, Chemotherapy-Related Nausea and/or Vomiting

PRIMARY OBJECTIVES: I. To measure the rate of adherence to selected Children's Oncology Group (COG)-endorsed supportive care clinical practice guidelines (CPG) recommendations at National Cancer Institute (NCI) Community Oncology Research Program (NCORP) sites. (Aim 1) II. To describe the possible influence of NCORP site size and the number of patients ...

Phase N/A

Patients are needed to participate in a clinical research study evaluating Cyclophosphamide 14.5 mg/kg/day IV on Days -6, -5, Busulfan, Pre-HCT Mesna on Days -2 and -1, Post-HCT Mesna, Post-HCT Cyclophosphamide 50mg/kg IV on Day+3, +4, Cyclophosphamide 50mg/kg/day IV on Days -5,-4, Mycophenolate mofetil, Sirolimus, Cyclophosphamide 50mg/kg/day IV on Days -2,-1, Fludarabine, G-CSF, Pre-HCT Mesna on Days -5 and -4, Pre-HCT Mesna on Days -6 and -5

This is a multi-center, single arm Phase II study of hematopoietic cell transplantation (HCT) using human leukocyte antigen (HLA)-mismatched unrelated bone marrow transplantation donors and post-transplantation cyclophosphamide (PTCy), sirolimus and mycophenolate mofetil (MMF) for graft versus host disease (GVHD) prophylaxis in patients with hematologic malignancies.